Bank of Montreal’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.7K | Hold |
1,400
| – | – | ﹤0.01% | 3196 |
|
|
2025
Q4 | $78.4K | Sell |
1,400
-1,000
| -42% | -$51.8K | ﹤0.01% | 3104 |
|
|
2025
Q3 | $115K | Hold |
2,400
| – | – | ﹤0.01% | 2932 |
|
|
2025
Q2 | $97.4K | Hold |
2,400
| – | – | ﹤0.01% | 2991 |
|
|
2025
Q1 | $105K | Hold |
2,400
| – | – | ﹤0.01% | 2907 |
|
|
2024
Q4 | $103K | Buy |
2,400
+105
| +5% | +$4.77K | ﹤0.01% | 2946 |
|
|
2024
Q3 | $101K | Sell |
2,295
-2,276
| -50% | -$97.5K | ﹤0.01% | 3246 |
|
|
2024
Q2 | $188K | Buy |
4,571
+305
| +7% | +$12.4K | ﹤0.01% | 3023 |
|
|
2024
Q1 | $187K | Buy |
4,266
+70
| +2% | +$3.02K | ﹤0.01% | 3083 |
|
|
2023
Q4 | $176K | Sell |
4,196
-12,721
| -75% | -$482K | ﹤0.01% | 3179 |
|
|
2023
Q3 | $726K | Hold |
16,917
| – | – | ﹤0.01% | 2229 |
|
|
2023
Q2 | $708K | Buy |
16,917
+56
| +0.3% | +$2.31K | ﹤0.01% | 2370 |
|
|
2023
Q1 | $702K | Sell |
16,861
-481
| -3% | -$20.2K | ﹤0.01% | 2265 |
|
|
2022
Q4 | $720K | Sell |
17,342
-5,973
| -26% | -$249K | ﹤0.01% | 2385 |
|
|
2022
Q3 | $1.01K | Buy |
23,315
+10,440
| +81% | +$446K | ﹤0.01% | 2169 |
|
|
2022
Q2 | $561 | Hold |
12,875
| – | – | ﹤0.01% | 2621 |
|
|
2022
Q1 | $598K | Buy |
12,875
+1,000
| +8% | +$44K | ﹤0.01% | 2701 |
|
|
2021
Q4 | $556K | Buy |
11,875
+339
| +3% | +$16.1K | ﹤0.01% | 2315 |
|
|
2021
Q3 | $561K | Sell |
11,536
-1,032
| -8% | -$51.3K | ﹤0.01% | 2812 |
|
|
2021
Q2 | $661K | Sell |
12,568
-28,585
| -69% | -$1.44M | ﹤0.01% | 2685 |
|
|
2021
Q1 | $2.02M | Buy |
41,153
+776
| +2% | +$41.4K | ﹤0.01% | 1796 |
|
|
2020
Q4 | $2.17M | Buy |
40,377
+18,427
| +84% | +$881K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $995K | Buy |
21,950
+18,480
| +533% | +$810K | ﹤0.01% | 1990 |
|
|
2020
Q2 | $150K | Sell |
3,470
-800
| -19% | -$33.1K | ﹤0.01% | 2881 |
|
|
2020
Q1 | $150K | Hold |
4,270
| – | – | ﹤0.01% | 2440 |
|
|
2019
Q4 | $195K | Sell |
4,270
-310
| -7% | -$12.3K | ﹤0.01% | 3176 |
|
|
2019
Q3 | $163K | Hold |
4,580
| – | – | ﹤0.01% | 3039 |
|
|
2019
Q2 | $182K | Sell |
4,580
-986
| -18% | -$38.8K | ﹤0.01% | 2977 |
|
|
2019
Q1 | $231K | Buy |
5,566
+986
| +22% | +$40.1K | ﹤0.01% | 2669 |
|
|
2018
Q4 | $168K | Buy |
4,580
+610
| +15% | +$26K | ﹤0.01% | 2679 |
|
|
2018
Q3 | $193K | Hold |
3,970
| – | – | ﹤0.01% | 2776 |
|
|
2018
Q2 | $171K | Sell |
3,970
-356
| -8% | -$15K | ﹤0.01% | 2843 |
|
|
2018
Q1 | $181K | Hold |
4,326
| – | – | ﹤0.01% | 2680 |
|
|
2017
Q4 | $188K | Hold |
4,326
| – | – | ﹤0.01% | 2707 |
|
|
2017
Q3 | $184K | Buy |
4,326
+1,070
| +33% | +$45.4K | ﹤0.01% | 2706 |
|
|
2017
Q2 | $140K | Buy |
3,256
+490
| +18% | +$20.7K | ﹤0.01% | 2828 |
|
|
2017
Q1 | $116K | Buy |
2,766
+1,741
| +170% | +$70.9K | ﹤0.01% | 2750 |
|
|
2016
Q4 | $40K | Buy |
1,025
+225
| +28% | +$9.16K | ﹤0.01% | 3187 |
|
|
2016
Q3 | $35K | Buy |
+800
| New | +$36.3K | ﹤0.01% | 3165 |
|
|
2016
Q1 | – | Sell |
-2,816
| Closed | -$144K | – | 4423 |
|
|
2015
Q4 | $144K | Buy |
+2,816
| New | +$144K | ﹤0.01% | 2596 |
|
|
2014
Q3 | – | Sell |
-1,400
| Closed | -$73K | – | 4452 |
|
|
2014
Q2 | $73K | Hold |
1,400
| – | – | ﹤0.01% | 3023 |
|
|
2014
Q1 | $66K | Sell |
1,400
-266
| -16% | -$12.6K | ﹤0.01% | 2999 |
|
|
2013
Q4 | $74K | Buy |
1,666
+266
| +19% | +$11.1K | ﹤0.01% | 2683 |
|
|
2013
Q3 | $54K | Hold |
1,400
| – | – | ﹤0.01% | 2791 |
|
|
2013
Q2 | $49K | Buy |
+1,400
| New | +$47.3K | ﹤0.01% | 2734 |
|
Other funds holding XPH
KWM
FCBT
Bank of Montreal's XPH Position: Q1 2026 in Review
Bank of Montreal held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q1 2026 at 1,400 shares worth $75.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.
Bank of Montreal first reported a position in XPH in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.17M in Q4 2020. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- Bank of Montreal held 1,400 shares of State Street SPDR S&P Pharmaceuticals ETF worth $75.7K as of Q1 2026.
- Bank of Montreal left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3196 holding.
- Bank of Montreal first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 45 quarters since.
- Bank of Montreal's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.17M in Q4 2020.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.